Schedule 13D ownership disclosure

NRX PHARMACEUTICALS INC

Security class unavailable · CUSIP: 629444100

Event date: 2021-05-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.2200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001654954-21-006305
Form type
SC 13D/A
Filer
Big Rock Partners Sponsor, LLC
CIK
CIK 1723217
Filed
May 26, 2021
Reporting period
May 24, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub